drugset / Trial / NCT05594615
Drug-Drug Interaction Study Between EDP-235, Midazolam, Caffeine and Rosuvastatin in Healthy Subjects
NaSingle-groupOpen-labelTreatment
Summary
A Drug-Drug Interaction study to assess the effects of EDP-235 on the Pharmacokinetics and Safety of midazolam, caffeine and rosuvastatin.
Timeline
- Start
- 2022-10-06
- Primary completion
- 2022-11-04
- Completion
- 2022-11-18
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Caffeine | Small molecule | — | — |
| Subject | EDP-235 | Unknown | — | — |
| Subject | Midazolam | Small molecule | — | — |
| Subject | Rosuvastatin | Small molecule | — | — |